Achieving efficient distribution of neural stem cells throughout the central nervous system (CNS) and robust generation of specific neurons is a major challenge for the development of cell-mediated therapy for neurodegenerative diseases. We isolated a primitive neural stem cell subset, double positive for LeX(Le) and CXCR4(CX) antigens that possesses CNS homing potential and extensive neuronal repopulating capacity. Le + cells into the CNS and a small, yet significant, number of donor cells differentiated into neurons. The isolation of a specific neural stem cell population could offer major advantages to neuronal replacement strategies.
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Key words: neural stem cells • transplantation • neurodegenerative diseases eural cell replacement is a potential treatment for neurodegenerative diseases, and transplantation of neural stem cells (NSC), differentiated from embryonic stem cells or isolated from embryonic and adult central nervous system (CNS), has been proposed as a possible therapeutic strategy. The donor cell origin, the route of cell delivery, either local CNS transplantation or systemic injection, and the mechanisms controlling NSC migration are critical issues that must be addressed. The use of primitive NSC that differentiate earlier in the neural developmental hierarchy and the comprehension of the rules of NSC engraftment may provide major advantages to the development of NSC transplantation. However, the relative rarity of primordial NSC and the absence of stem cell-specific markers limit their identification and isolation. Moreover a finding common to stem/progenitor cell transplant experiments is that the majority of cells remain immature, and, when they are grafted into non-neurogenic areas of the adult CNS, they predominantly differentiate into glial cells, not into neurons. The engraftment potential also depends on their homing ability and "seeding" efficiency.
Here we provide the first evidence of efficient in vivo neuronal generation in the murine brain following transplantation of an enriched population of NSC derived from adult and embryonic mouse neurospheres selected for the simultaneous expression of LeX [stage specific embryonic antigen 1 (ssea- 
MATERIALS AND METHODS

Isolation of LeCX cells
NSC were isolated from E.13.5 forebrain germinal zones and from the adult subventricular zones (SVZ) of C57BL/6 mice as described previously (1) . Single cell suspension was seeded at a density of 100,000 cells/ml in neurobasal medium (GIBCO Invitrogen), containing B-27, N2 (Invitrogen), epidermal growth factor (EGF, 20 ng/ml), fibroblast growth factor (FGF, 20 ng/ml; Sigma-Aldrich), and penicillin (100 U)/streptomycin (100 μg/ml; Invitrogen). Cells were grown in uncoated T75 plastic flasks (NUNC), as free-floating clusters (neurospheres). The cultures were passaged every 5−7 days as described previously (1) . Cells used for separation were passaged three to five times.
Cell sorting
Cells were labeled with fluorescein isothiocyanate (FITC) conjugated anti-Le antibody (anti SSEA1, 1:200; BD) and R-phycoerythrin (R-PE) conjugated CXCR4 antibody (rat, 1:100, BD) for 30 min at 4°C and then rinsed twice with serum-free media by centrifugation at 4°C. In the case of GFP cells used for transplantation, we used unlabeled anti-Le (1:200 BD) for 30 min followed by APC goat Anti-Mouse Ig (BD; 20 min) and CXCR4 (R-PE). Isotype-matched mouse immunoglobulin (BD) and cells labeled only with the secondary antibody served as controls. Flow cytometric sorting was conducted using a FACS Vantage SE (BD). Sorting of antibody-labeled cells was performed using FACS gates set with unlabeled cells. LeCX positive and negative cells were collected separately in plating medium. We performed 20 independent FACS analyses.
LeCX positive cell culture and differentiation
Sorted cells were plated in the presence of EGF and FGF (1) . LeCX cells were seeded at
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equivalent densities (ranging from 1 to 10 cells per microliter depending on the number of cells isolated). The number of neurospheres was counted after 10−14 days in vitro. For differentiation, LeCX-derived neurospheres were plated onto poly-L-lysine-coated four-well plates (NUNC) in Neurobasal medium supplemented with B27 without growth factors and with 1% fetal bovine serum (FBS; Sigma). The cells were differentiated for 7 days. For in vitro priming (2) , neurospheres were cultured in neurobasal plus N2, 20 ng/ml bFGF, 1 µg/ml laminin, 5 µg/ml heparin, 10 ng/ml NGF (Invitrogen), and 10 ng/ml Shh (R&D Systems, Minneapolis, MN). A half-volume of medium was replaced once every 1−2 days. Cell proliferation and differentiation were assessed in triplicate in five independent experiments.
Immunocytochemistry on cell culture
Cultured cells were fixed in 4% paraformaldehyde (PFA, 10 min) at room temperature (RT). After being rinsed with phosphate-buffered saline (PBS), and preincubation in a mixture of 5% normal serum and 0.25% Triton X-100 in PBS the cultures were incubated with the primary antibodies (see below) overnight at 4°C. The following proteins were evaluated: nestin, vimentin, β-III-tubulin (TuJ-1), neurofilament (NF) M and H phosphorylated, nuclear neuralspecific antigen (NeuN), O4 (mouse monoclonal antibodies 1:200, Chemicon), choline acetyltransferase (ChAT), insulin gene enhancer protein (Islet-1) (rabbit polyclonal, Chemicon), microtubule associated protein 2 (MAP2, 1:200 mouse monoclonal Sigma Aldrich), mouse Cy3 conjugated glial fibrillar acidic protein (GFAP, 1:400, Sigma-Aldrich), RC2 (monoclonal mouse IgM 1:100; Developmental Hybridoma Bank; Iowa City, IA), and Alexa 488 rabbit polyclonal antibodies recognizing GFP (1:400, Molecular Probes). After repeated rinses in PBS, the primary unconjugated antibodies were further incubated with FITC and RPE or tetramethylrhodamine isothiocyanate (TRITC) conjugated secondary antibodies (DAKO; 1 h, dark, RT) in PBS and then rinsed in PBS and coverslipped. Controls with omission of primary antibodies were made, with no positive signals detected. For quantitative analyses of cell phenotypes of LeCX differentiated in vitro, 10 monolayer fields (>200 cells) were randomly chosen for each sample. The percentage of any given phenotype in a sample was obtained by averaging proportions of a specific cell type in each of the 10 fields. At least four samples were counted for each treatment group.
Neurosphere sections and immunohistochemistry on fetal and adult normal brain
Neurospheres were fixed in 4% PFA, cryoprotected in 30% sucrose, and cut at 10 μm. Sections were permeabilized with 0.1% Triton X-100. Brains were fixed in 4% PFA after transcardial perfusion and were processed as paraffin sections or cryostat sections.
The sections were incubated with antibodies against the following proteins: CXCR4 antibody (rat, 1:100; BD PharMingen), SSEA-1 (MMA clone 1:200; Becton Dickinson), RC2 (monoclonal mouse IgM 1:100; Developmental Hybridoma Bank; Iowa City, IA), and nestin (mouse monoclonal 1:100; Chemicon). The specificity of immunolabeling was verified in all experiments by controls in which the primary antibody was omitted. Cell counts of positive cells were performed at ×40 magnification on eight fields from each section in triplicate.
Muscle differentiation in vitro
To test the ability of LeCX cells to undergo differentiation into myogenic phenotype, we Coculture with 3T3 cell line (ATCC) was performed as control. Furthermore, we evaluate the effect of the Wnt signal to promote muscle differentiation of LeCX cells. We cultured selected LeCX cells in skeletal muscle growth medium (Promocell) supplemented with Wnt3a 10 ng/ml (R&D Systems) for at least 10 days. To induce cell fusion into myotubes, we shifted the medium to skeletal muscle differentiative medium (Promocell) with or without Wnt3a. Differentiative medium does not contain serum or growth factors. After 14 days of culture, the percentage of differentiated myotubes containing two or more nuclei was evaluated.
The immunocytochemistry for the following myogenic proteins was performed as described previously (3): desmin, myosin heavy chain, (MyHC), α-SR actin myogenin, and Myf5. For the evaluation of smooth muscle phenotype, cells were stained with anti-SMA antibody (SigmaAldrich). The primary antibodies were applied overnight at 4°C. The cells were rinsed in PBS and then incubated with FITC or R-PE conjugated secondary antibodies (DAKO) for 1 h at RT. As internal control, cells were incubated only with the secondary antibody. Murine primary fibroblasts were also used as negative controls. Slides were then counterstained with 4′,6-diamidino-2-phenyindole,dilactate (DAPI, Sigma-Aldrich) mounted in PBS/glycerol and observed with a Zeiss Axiophot microscope. Each experiment was performed at least three times in triplicate.
Western blot
Fifty micrograms of protein extract from LeCX culture either induced or not to a muscle phenotype were separated on a 9% acrylamide gel and electrophoretically transferred to a nitrocellulose membrane. The blots were probed for expression of desmin, MyHC, Myf5, and myogenin. Secondary peroxidase-conjugated antibodies were used, and the signal was detected with an ECL detection kit (Amersham, Buckinghamshire, UK). Primary murine myoblasts and 3T3 cells were used as positive and negative controls, respectively.
Real-time RT-PCR
For the evaluation of myogenic transcripts, total RNA was extracted from LeCX cells in neuronal growth medium and after muscle induction. Murine myoblasts and 3T3 cells, both grown in skeletal muscle growth medium and Wnt3a, were used as controls. Total RNA was prepared using the EUROzol isolation kit (EuroClone). Reverse transcription was carried out as follows: 2 μg of total RNA from each sample were reverse-transcribed using random primers by the Ready-To-Go TM "You-Prime First-Strand Beads" kit (Amersham Biosciences), according to the manufacturer's recommendations. One microliter of the generated cDNA was used as template for each reaction in real-time quantitative PCR analysis, using Assays-on-Demand TM Gene Expression Products in an ABI PRISM ® 7700 Sequence Detection System (Applied Biosystems, Foster City, CA). The following gene expression assays were detected: MYOD1 (Mm00440387_m1), MYF5 (Mm00435125_m1), myosin (MYHCMm00440354_m1), and desmin (DES) (Mm00802455_m1). Eukaryotic 18S rRNA (Hs99999901_s1) was used as endogenous control to normalize all the above target genes; to determine relative quantification, the comparative threshold cycle (C t ) method was used. All Assays-on-Demand TM Gene
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Expression Products consist of target assays to amplify and detect expression of specific RNA sequences.
In vivo evaluation of skeletal muscle differentiation
A total of six 6-to 8-wk-old C57BL/6 and six 6-to 8-wk-old mdx mice were transplanted with Le + CX + cells grown in muscle condition, without coculturing, for at least 10 days; 1 × 10 6 LeCX/GFP+ cells that were resuspended in a total volume of 100 μl saline solution were injected directly into the right tibialis anterior (TA) muscle of C57BL/6 mice. Forty-eight hours before cell transplantation, muscle degeneration was induced into nude mice by intramuscular injection of 10 μg/ml cardiotoxin (ctx) dissolved in PBS (Latoxan, Rosans, France). In mdx mice, sex mismatched transplantation was performed by transplanting male LeCX cells into female animals (1×10 6 LeCX). No ctx injection was administered to mdx mice. The mice were killed 2 months after cell transplantation and the right skeletal muscle TA was analyzed by immunohistochemistry for donor-derived GFP expression and dystrophin expression in mdx mice (rabbit Dys8) as described previously (3) . Fluorescent in situ hybridization (FISH) analysis was performed on frozen sections of right TA skeletal muscles with a chromosome Y satellite probe direct-labeled with rhodamine (Appligene Oncor, Watford, UK) to detect male donor cells into female mdx mice (3). Positive controls were male muscle sections, and negative controls were muscle sections from nontransplanted female mice. Slides were observed using an Axioskop Zeiss microscope. Myofiber count was performed as described previously (3).
Endothelial differentiation
To induce the endothelial phenotype, we cocultured LeCX/GFP cells with a murine endothelial cell line (H5V; kindly provided by Prof. E. Dejana Istituto Farmacologico M. Negri Milano, Italy; ratio 1:1) in DMEM plus 20% FBS. Coculture was maintained for 2−5 days. For evaluation of the endothelial marker, cells were fixed in PFA for 5 min, washed with PBS and incubated overnight with the primary antibodies against anti-mouse VE cadherin (1:100, rat; Research Diagnostics) and anti-mouse CD31 (1:100; Santa Cruz Biotechnology). R-PE appropriate secondary antibodies were applied for 1 h. Internal controls with cells incubated only with the secondary antibody were performed. All assays were performed in triplicate and repeated three times.
We also cocultured 1 × 10 5 Le + CX + cells, deriving from male mice, separated by a trans-well membrane (pore size 0.4 μm; Corning Costar) from the H5V endothelial monolayer of mouse female origin (4).
After 48 h, the cells in the upper chambers were recovered and placed on slides as cytospin. For immunocytochemistry and FISH analysis, cells were fixed with methanol and acetic acid (3: 1). The slides were then denaturated with 70% formamide in 2× SSC at 60°C, dehydrated, and air dried. The probes for the mouse X and Y chromosome (Cambio) were denaturated at 60°C applied on denatured slides and hybridized overnight 37°C. Then the probe was washed off in 50% formamide/2× SSC and in 2× SSC for 5 min at 37°C. After FISH, we performed immunocitochemistry using Rat-antibody against Ve-cadherin and CD31 for 1 h RT. The slides were washed and labeled with secondary antibody Alexafluor-647. Nuclei were counterstained with DAPI. All assays were performed in triplicate and repeated three times.
Analysis of pluripotent markers
Le + CX + cells were cultured in Neural growth medium or in ES medium on gelatin coated plates. ES medium contains DMEM (GIBCO) with 15% FBS (heat inactivated), 1% nonessential amino acids, 1% glutamine, 0.001% 2-mercaptoethanol, ESGRO 10 5 units/ml (Chemicon).
Oct4 (Mm00658129_gH) and Rex1 (Mm01194088_m1) transcripts were evaluated by real-time RT-PCR analysis as described above for myogenic transcripts.
Oct4 immunocytochemistry was performed as above described using rabbit anti-oct4 antibody (1:200; Chemicon) followed by TRITC conjugated secondary antibody (Dako).
We derived also Le 
SDF effects on LeCX chemotaxis, transmigration, proliferation, and apoptosis
A sixwell cell migration Transwell (Corning-Costar) with a 8 μm pores membrane was used. The cells were seeded at 5 × 10 5 cells/ml per well in Neurobasal medium without growth factors on the top of the membrane. GFP cells were used to track the migrated cells. For transmigration assays, H5V endothelial cells were grown in DMEM plus 10% FBS on polycarbonate transwell insert for 5 days until they formed a uniform monolayer (6) . To create a chemokine gradient, Neurobasal medium was added into the inner chamber and CXCR4 (5−500 ng/ml; R&D Systems) was added into the outer chamber. For inhibition of the chemokine activity by AMD3100 (Sigma), the CXCR4 inhibitor (1 μM) was added to the cells for 15 min before being transferred to the upper compartment of the microchamber. After 4 h (chemotaxis) or 8 h (transmigration), cells remaining on the upper surface of the filters were mechanically removed, and the ones migrated to the lower surface were counted at ×400 in five random fields per filter. Assays were performed in triplicate and repeated three times in independent experiments. Repeated-measures ANOVA was used for statistical analyses for chemotaxis and transmigration assays.
Proliferation and apoptosis assays
To evaluate proliferation, positive and negative fractions were cultured in growth factors for 48−72 h after sorting with/without SDF ± growth factors. For bromodeoxyuridine (BrdU) labeling, cells were incubated for 16 h with BrdU at a final concentration of 10 μM in culture medium. Subsequently, cells were fixed, permeabilized, and stained with anti-BrdU fluorescent marker by a BrdU Flow Kit (BD). The BrdU incorporation was assessed by FACS. The percentage of cells undergoing apoptosis induced by growth factor starvation was determined with FITC-conjugated annexin-V (Sigma). Sorted cells were plated in 12-well plates and cultured for 5 days without growth factors with or without SDF (100 ng/ml). Cells were collected and stained at RT for 15 min in 200 µl of buffer containing FITC-annexin-V (5 µl). Annexin-V + cells correspond to apoptotic cells. Each assay was performed in triplicate and repeated three times.
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Signaling assay
Sorted cells were cultured in neurobasal medium without growth factors for 12 h and then incubated in the presence of 100 ng/ml SDF or diluent at 37°C for various time periods (0, 5, 15, 60 min). After the reactions were stopped by washing with ice-cold PBS and centrifugation, the cells were resuspended in ice-cold extraction buffer. Equal amounts of proteins were separated on 8−12% acrylamide gels and electrophoretically transferred to a nitrocellulose membrane. Membranes were blocked with 1% BSA and incubated 1 h at RT or overnight at 4°C with specific primary antiphosphokinase antibodies phospho-p44/42 MAP kinase (Thr204/Tyr204) antibody (Erk1 and Erk2) or p38 MAP kinase (Cell Signaling Technology, Beverly, MA) used at a dilution of 1:200 to 1:1000. The secondary peroxidase-conjugated antibodies were used at 1:10,000 for 1 h. The blots were developed by using ECL Western blotting detection kit (Amersham, Buckinghamshire, England).
These assays were performed in triplicate in three independent experiments.
Transplantation
As donor cells for in vivo experiments, we used transgenic mice expressing a specific gene reporter. Transgenic TgN(ACTbEGFP)1Osb mice expressing an "enhanced" GFP cDNA under the control of a chicken β−actin promoter in all tissues (7) and B6.Cg-TgN(Thy1-YFP)16Jrs mice express spectral variants of GFP (yellow-YFP) at high level in motor and sensory neurons as well as in subsets of central neurons (8) . All transgenic animals were purchased from the Jackson Laboratory (Bar Harbor, ME). All animal experiments were performed according to institutional guidelines in compliance with national and international law and policies.
LeCX positive and negative cells and unselected neurospheres from GFP/Thy1-YFP mice were used for transplantation after FACS selection. Cells were transplanted into the lateral ventricles of anesthetized 1-to-2-day-old mice pups and adult (6−8 wk adult) as described previously (9); 2−3 μl of cell suspension (100,000 viable cells/μl) were slowly injected. For intravenous transplantation 4-to 6-wk-old C57BL/6 mice were transplanted into the tail vein with 50 μl (1×10 6 cells) of LeCX cell suspension using a 25-gauge needle. In some experiments of intravenous transplantation, a contemporaneous direct injection of SDF was performed. For inhibition of the SDF/CXCR4 axes, AMD3100 (Sigma-Aldrich), the CXCR4 inhibitor (1 μM) was added to the cells for 15 min before transplantation. Cells injection was administered after anesthesia as described previously (10) . As control, mice received a suspension of SDF (3 μg in 3 μl of PBS; R&D Systems) or PBS through a Hamilton syringe. Two months after transplantation, the animals were killed. At least six animals for each experimental group were analyzed.
Tissue analysis
The animals were killed, perfused, and fixed with 4% PFA in PBS (pH 7.4; ref 11). The brain was isolated, immersed in PFA solution for 1 h and then in sucrose 20% solution in PBS (pH 7.4) overnight and frozen. The tissues were cryosectioned and mounted on gelatinized glass slides. Cerebral tissue was cut in coronal plane from the frontal lobes (10 or 50 μm for stereological cell count). All CNS sections were blocked with 1% fetal calf serum in PBS and permeabilized with 0.25% Triton X-100. Sections were processed for multiple markers to determine the cellular phenotype of GFP/YFP-labeled cells. Immunohistochemistry was performed as described previously (11) for the following proteins: neuronal nuclei (NeuN), NF, TuJ1, MAP2, nestin, vimentin, ChAT, tyrosine hydroxylase (TH), GAD 67, O4, GFAP, CD45, CD14, F4/80, and GFP/YFP. Coexpression of GFP/YFP and tissue specific markers was evaluated by conventional fluorescence microscope (Zeiss Axiophot) and by laser confocal scanning (Leica TCS SP2 AOBS) microscopic analysis. A stereological count of total GFP/YFP positive cells and double-labeled cells with neural and glial markers was conducted using a modified version of the optical fractionator method (12) on every fifth section in selected areas with three ROIs (0.3×0.3 mm). Resulting numbers were tallied and multiplied by tissue thickness (50 μm) and the number of intervening sections (n=5) as described previously (13) . Repeatedmeasures ANOVA was used for statistical analyses. FISH analysis for Y chromosome combined with GFP/YFP detection was done using a Cy3 Y chromosome probe (Cambio) as described previously (14) . Detection of FISH signals was done by Z-stack analysis confocal analysis.
RESULTS
Identification and isolation of CNS derived LeX(ssea-1) + /CXCR4 + (LeCX) cells
To identify and isolate putative NSC, we performed immunohistochemistry and FACS to examine single cell suspension from embryonic and adult neurospheres for the expression of the cell surface marker LeX and for the chemokine receptor CXCR4. LeX + cells represented 26.4 ± 7.2% of all the embryonic-derived neurosphere cells (Fig. 1A) , while CXCR4 was present in 63.6 ± 11.8% of these cells ( We examined the expression of LeX and CXCR4 in the germinal regions of the murine developing brain (E13.5). Immunohistochemical analysis revealed that radial glia cells, identified by RC2 immunoreactivity, express moderate levels of LeX in the soma and an intense signal in the endfeets of the ventricular surface ( Fig. 1F-H ). CXCR4 expression was evident in the marginal zone, in the cortex, basal forebrain, and ventricular zone. CXCR4 and LeX coexpression was detected in radial glia ( Fig. 1I-K ). In the adult SVZ region, we confirmed the described previously expression (15) (Fig. 1O ), astroglial cells (Fig. 1P), or oligodendrocytes (Fig. 1Q) Fig. 2A-F) . Some of these were cholinergic as demonstrated by the expression of Islet-1 (Fig. 2J-L) and ChAT ( Fig. 2G-I) 15.4 ± 5.5% in embryonic cells and 9.7 ± 4.8% in adult cells. Wnt signaling is involved in embryonic myogenesis and is sufficient to induce the myogenic specification of murine muscle-derived CD45(+) stem cells (18) . Furthermore, Wnt3a expression is sufficient to induce myogenesis in the embryonic cell line P19 cells (19 (Fig. 3E-F) . The myogenic phenotype was confirmed by the detection of myogenic markers by real time RT-PCR (Myf5, MyoD, desmin, MyHC; Fig. 3N ) and Western blot (Myf5, desmin, myogenin, MyHC; Fig. 3M ). MyHC was detected after 10 days in muscle differentiative conditions. /GFP+, we observed the presence of 1.9 ± 0.13% GFP positive muscle fibers in C57BL/6 mice ( Fig. 3G ) and 2.2 ± 0.81% donor-derived dystrophin positive fibers in mdx mice, counted in cross sections ( Fig. 3H and I) . It has been recently described that murine neurospheres can convert into stable endothelial cells, when cocultured with human endothelial cells (20) . Thus, to test whether LeCX have the ability to differentiate into the endothelium, we cocultured LeCX/GFP positive cells with a murine endothelial cell line. Under these conditions, both E.Le (Fig. 3K) . We demonstrated that Le + CX + in culture conditions for ES in the presence of LIF expressed Oct4 and Rex1 transcripts. In neuronal growth medium, the Oct4 and Rex1 level was diminished of 20-and 14-fold, respectively. Furthermore, to fully address this issue, we derived Le + CX + cells from mice carrying GFP under the control of the Oct4 promoter enabling the assessment of Oct4-GFP gene expression by simply examining the presence of a GFP-positive signal. We detected 4.2 ± 1.6% Oct4-driven GFP-positive cells, when cultured in the presence of LIF (Fig. 3L) . In neuronal growth medium, less than 0.1% of Oct4 positive cells were detected.
Chemoattractant effects of SDF on LeCX migration and transmigration through endothelium in vitro
To investigate whether selection of Le potential but also the migratory potential of neurosphere-derived cells, we performed a Boyden chamber-based migration assay and endothelial transmigration analysis to quantitatively evaluate LeCX migration in vitro.
To directly estimate the chemoattractant effects of SDF on NSC migration, we used various concentrations of purified SDF to induce LeCX migration. SDF stimulation resulted in a significant chemoattractant and transmigration effect on LeCX in a dose-dependent manner (P<0.001; Figs. 4-5A and B) . Significant increases in cell migration and in the number of Le + CX + crossing the endothelial monolayer were seen at SDF concentrations as low as 50 ng/ml. In addition, cell migration could be significantly reduced by pretreatment of LeCX cells with the specific CXCR4 inhibitor AMD3100. (Fig. 4H) .
Intracerebroventricular transplantation of LeCX cells
To determine whether Le + CX + could become neurons also in vivo, we transplanted these cells into the cerebral ventricles of both newborn mice and adult mice (n= 6 for each tested condition). We used both embryonic and adult LeCX cells. To trace the grafted cells, two donor mice strains were used: β-actin-GFP and Thy1-YFP transgenic mice that express the gene reporter ubiquitously and only in a subset of neurons respectively. All recipient animals showed evidence of LeCX donor cells engraftment. At 2 months from transplantation, many GFP/YFP cells were found throughout the cerebral ventricles and had migrated into the white matter and in the gray matter of the midbrain surrounding the cerebral aqueduct. GFP/YFP cells had migrated at longer distance (0.5 mm) from the ependyma and were found in the pyramidal and molecular layer of the hippocampus and in the striatum. Some cells had migrated much further, up to 1−2 cm, and were located in the upper cerebral cortex (Fig. 6 and 7) . the other hand a mean 30% cell density decrement when compared with the corresponding neonatal condition. Also, in adult animals, Le + CX + fraction gives rise to a significant higher number of donor cells, when compared with negative fraction and unselected cells (Fig. 8C) .
To investigate the differentiation state of engrafted cells, brain sections were examined by immunofluorescence microscopy. The activation of Thy1 neuron specific transgene provides direct evidence for the acquisition of a neuronal phenotype by LeCX-derived cells. In neonatal brain YFP-neuron density was 213.4 ± 52.8/mm 3 (cortex), 348.4 ± 72.4/mm 3 (striatum), and 674.2 ± 102.8/ mm 3 (hippocampus; (Fig. 8A and B) .
GFP/YFP positive cells from LeCX positive fractions exhibited various neuronal morphologies ranging from simple bipolar cells such as immature migratory neurons to more complex phenotypes. In particular, in the CA1 pyramidal cell layer of the hippocampus, we detected GFP/YFP-positive cells with pyramidal morphologies and appropriate dendritic orientation (Fig.  6G -L, Movie 1). In the cortex we also observed cells with the morphological features of pyramidal neurons displaying large angular somas and rich trees of branching and spine-bearing apical and basal dendrites. These cells showed vertical alignment, perpendicular to the cortical layers, with the apical dendrite extending toward the pial surface ( Fig. 6D-F) . Numerous spines on their processes indicated a functional maturation of these grafted cells. Other GFP+ grafted cells differentiated into multipolar cells with interneuron-like morphologies. Immunocytochemistry using the neuron-specific markers NeuN, TuJ1, NF, and MAP2, followed by confocal z-series analysis and three-dimensional reconstruction, revealed that ~1:3 GFP+ cells acquire neuronal labeling into the cortex, hippocampus and striatum ( + cells after a period of culture "priming" we found a higher proportion of mature neurons. Cells identical to principal pyramidal neurons in the hippocampus and multipolar neuronal cell types in the cortex were observed. In neonatal brain a high fraction of GFP+ cells differentiated into neurons, as determined by TuJ1 staining, including 54.4 ± 12.6% in the cortex, 44.4 ± 12.9% in the medial septum, 69.3 ± 11.0% in CA1, and 73.8 ± 12.4% in DG. Cells with pyramidal feature were observed also in the cortex of adult recipients.
Since these phenotypes were not described previously after NSC transplantation, we wondered whether cell fusion occurred between LeCX positive cells and endogenous neurons. In female mice transplanted with male GFP/YFP transgenic LeCX cells, we detected no trace of Y chromosome in no GFP/YFP neuronal cells examined using FISH (n=1775 GFP and n=565 YFP cells analyzed in 12 recipients, 6 neonatal and 6 adult recipients). This study suggests that stable fusion did not occur (Fig. 9M-O, Movie 3) . Immunohistochemistry revealed that the engrafted donor cells had differentiated into neurons synthesizing different neurotransmitter subtypes. A proportion of donor-derived cells (25.8±7.4%) expressed glutamic acid decarboxylase (GAD 67), the rate-limiting enzyme for GABA synthesis indicating a GABAergic phenotype; a small proportion was immunoreactive for tyrosine hydroxylase or choline acetyl transferase (Fig. 9J-L) .
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Systemic transplantation of LeCX cells
Based on chemotaxis and transmigration observations, we examined the SDF potential to recruit Le + CX + cells in vivo after intravenous administration.
After injection through the tail vein of C57BL/6 mice and coadministration into the brain of SDF, both E.Le + CX + and A.Le + CX + cells migrated into cortical and subcortical regions (n=6 for each group). Many donor cells were found in the meningeal layer and perivascular areas. The majority of these cells were round-shaped, negative for hematopoietic markers and positive for vimentin and nestin (Fig. 10A-C) .
Some cells presented a more complex ramified phenotype with neuritic extensions (Fig. 10D-I) . FISH analysis for Y chromosome in sex-mismatched transplantation ruled out the cell fusion event as mechanism of neurons generation (n=235 GFP cells and n=77 YFP cells analyzed in 6 recipients; Fig. 10J-L (Fig. 10D-I diseases.
The present study demonstrates for the first time that double positive LeX and CXCR4 populations, derived from both embryonic and adult neurospheres, are highly enriched for NSC that possess CNS homing potential and multilineage repopulating capacity in vivo. Extensive generation of region-specific neurons is achievable by means of intraventricular and, to a lower extent, intravenous administration of LeCX cells. Moreover, the potential of neurosphere cells to cross the endothelial barrier in vitro and in vivo resides within the Le + CX + fraction.
LeX is a fucose-containing trisaccharide highly expressed on embryonic stem cells in the developing brain and adult subventricular zone. LeX has been recently proposed as a possible marker to identify adult NSC in vivo (15) . We verified whether this marker could be used to select long-term repopulating cells from both adult and embryonic derived neurospheres.
Furthermore, we tested whether the selection of NSC expressing simultaneously CXCR4 and LeX can enrich the cell fraction with homing ability and engraftment potential. In fact, in hematopoietic transplantation, both homing and high-level multilineage repopulation of human CD34+-enriched cells are dependent on SDF/CXCR4 interactions. The chemokine receptor CXCR4 is highly expressed in the developing nervous system and in rodent and human NSC (21) . LeX probably plays an important role in regulating the stem cell niche since it is present in the extracellular matrix (22) .
LeCX positive cells are NSC
The double positive LeX/CXCR4 fraction contains the majority of clonogenic cells, whereas the negative one rarely generates neurospheres. It is important to note that Le + CX + cells are not only able to self-renew but they can also differentiate into neurons and macroglia cells. Furthermore, a modification of the described previously priming method (2) allowed a robust neuronal differentiation in vitro, including the cholinergic phenotype.
Recent studies have attempted to identify NSC from the CNS using different strategies like cell size combined with a number of negative selection criteria (23) or the exclusion of the Hoechst 33342 (24) . However, cell selection based on surface antigens is a simpler and more reproducible enrichment method. In this study contemporaneous selection for CXCR4 and LeX resulted in NCS with optimal differentiative properties, offering some cues to their in vivo identity. In adult SVZ, there are a few distinct cells that strongly express LeX, as described previously (15) . Simultaneously, we found that some of these cells co-express CXCR4.
In the E13.5 brain, radial glia cells expressed LeX and CXCR4 with a strong LeX signal in their feet at the ventricular layer. It has been recently demonstrated that radial glial cells serve as neuronal progenitors in all regions of the CNS, and interestingly LeCX cells can acquire in vitro a radial glia phenotype expressing the RC2 radial glial specific protein. Since we isolated LeCX cells from neurospheres, and CXCR4 and LeX are common markers for stem cells, the minimal interpretative hypothesis is that radial glia and Le + CX + cells share common characteristics.
LeCX multipotentiality in non-neural phenotypes
LeCX cells demonstrate their potentiality to differentiate into both neural and non-neural cells when exposed to appropriate signals.
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As described previously (17, 19, 20) , we observed the acquisition of a skeletal muscle and endothelial phenotype in coculture conditions. In the presence of murine myogenic cells, Le + CX + expressed early myogenic markers and, when induced to differentiate, they fused into mature multinucleated myotubes. Wnt/β-catenin signals are important in ES maintenance, neural proliferation and myogenesis. Wnt3a is capable of maintaining and/or inducing expression of myogenic transcription factors and is sufficient to induce muscle phenotype in embryonic cells (19) . In this study, we demonstrated that the Wnt3a signal promotes a myogenic phenotype in LeCX cells, without coculture, ruling out cell fusion.
The smooth muscle differentiation was the most frequent non-neural phenotype obtained, probably due to embryonal germ layer similarities.
We investigated the ability of LeCX, after in vitro exposure to Wnt3a, to contribute to muscle regeneration and restore dystrophin expression in dystrophic muscle after intramuscular transplantation. We found a 1% proportion of donor-derived fibers, mainly originated by cell fusion, a percentage comparable to somatic cell fusion as already observed in other adult somatic stem cells like BM-derived cells (3) . Fusion is a physiological and spontaneous phenomenon in myoblasts. Thus, the fusion events between Le 
CXCR4-SDF pathway enhances LeCX migration, proliferation, and survival
Understanding the signals involved in guiding migrating progenitors to their appropriate final destination is an essential achievement for the development of strategies for NSC-mediated repair.
Furthermore, the ability of NSC to migrate across the endothelium is a critical prerequisite in the homing and successful engraftment of these cells when transplanted into vessels.
One distinguishing characteristic of Le + CX + cells vs. negative ones is their migratory capacity through the endothelial barrier, in response to the SDF signal. The CXCR4/SDF signal facilitates the LeCX transendothelial migration also by modulating cell adhesion. SDF blockade by AMD3100 on LeCX prevents their migratory capacity. LeX is one ligand for E selectin, a glycoprotein that is expressed in activated endothelial cells. Adhesion mediated by endothelial E selectin and LeX expressed on NSC may contribute to their interaction with the endothelial layer. In addition to migration enhancing, SDF improves proliferation of LeCX cells. Interestingly, the CXCR4 antagonist AMD3100 inhibited their proliferation suggesting that the endogenously produced SDF may function as an autocrine or paracrine growth factor. The chemokine SDF has been involved in promoting the survival of CD34 + hematopoietic progenitors (27) . We first provide evidence that SDF can protect LeCX cells from growth factor starvation-induced death. These results indicate that the CXCR4 receptor stimulates cell motility and invasion and promotes survival and proliferation by activation of specific intracellular molecular pathways.
LeCX cells efficiently generate new neurons in brain
A major obstacle in the use of primitive NSC is that typical neurospheres failed to generate neurons in vivo when grafted into non-neurogenic areas of the CNS, and preferentially generated glial cells (28) . It could be hypothesized that only a small population of neurosphere cells is able to differentiate into neurons after intracerebral grafting. This study provides evidence that LeCX cells can efficiently generate mature neurons in a region-specific manner and that this phenomenon can be partially modulated using appropriate signals. Widespread dispersion of injected LeCX in all directions from ventricles to cortical layers was achieved, suggesting that this cell fraction has a high migratory potential.
In the comparison of LeCX positive to negative populations and unselected neurospheres for cell generation in recipient brains, three findings emerged: a high donor cell density, distant migratory pathways, and efficient neuronal generation in the Le + CX + mice cohorts. The major transplantation efficiency in vivo is likely due to the high proliferation, survival, and migratory capacity of Le + CX + that we demonstrated also in vitro.
Despite this high proliferative ability, we did not observe the formation of tumors. To our knowledge, no tumor has been reported after NSC transplantation, in contrast to the possible neoplastic proliferation described after ES transplantation (29) . The transplant was allogenic, however, the donor and recipient mice had identical background differing only for the expression of the reporter gene.
Although we used no immunosuppression or irradiation methods, the CNS tissues analyzed did not exhibit any sign of immunoreaction, such as microglial activation or leukocyte infiltration.
We showed that primed Le + CX + could generate cells with the morphological characteristics of intrinsic pyramidal neurons, including elaborated apical and basal neuritic extensions and vertical alignment within appropriate cortical and hippocampal layers. These complex phenotypes were not described previously. FISH analysis in sex-mismatched transplantation experiments supports that stable fusion between the LeCX and recipient neurons does not occur. Thus, the mechanism responsible for the neuron formation from the Le + CX + is the direct differentiation pathway both after direct or systemic transplantation.
To obtain specific type of neurons the use of priming procedure before transplantation is a useful strategy. It has been described that fetal human neural stem cells (hNSCs) may acquire a cholinergic phenotype in a region-specific manner after in vitro priming procedure (2) . Furthermore these cells when grafted into adult rat spinal cord with motoneuron degeneration develop into cholinergic neurons that innervate peripheral muscle with concomitant improvement of motor function (30) .
Intravenous administration of neural stem cells is a noninvasive method that may be suitable for clinical applications. Thus, we evaluated the feasibility of this route and whether the homing of LeCX cells could be induced through chemotactic signals. SDF coadministration was well tolerated by all mice, guiding LeCX positive cells to the brain. These observations confirm the important role of SDF in migration of neural precursors also across the blood brain barrier. The number of donor-derived neurons identified in the brain tissue after intravenous transplantation was very low. In addition, fully mature neurons were rarely evident, while the immature phenotype was definitively predominant. Small-sized GFP-cells with undifferentiated appearance were often observed, frequently associated with blood vessels. These cells expressed the progenitor markers nestin and vimentin. However, it is important to point out that donor cells were transplanted intravenously in control brain-uninjured mice, in which only SDF injection had been performed. This nonpathological condition only partially mimic an injury able to attract exogenous and potentially reparative cells compared with other situations such as brain injury (31) and ischaemia (21) . It has been recently demonstrated that adult NSC injected intravenously into an animal model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE) in the mouse, can migrate to demyelinating areas of the central nervous system and differentiate into mature brain cells (31) . NSC migrate, differentiate, and integrate after intravenous transplantation in animal models with forebrain ischemia (32, 33) and also in an animal model with striatal degeneration mimicking Huntington's disease (34) .
SDF-1 and its receptor CXCR4 are critical mediators for the ischemia-specific recruitment of circulating progenitor cells (35) , and SDF is expressed also in ischemic brain (21) . As a result of injury, surviving or invading glial cells (including activated astrocytes and microglia) produce chemoattractants such as SDF-1 that may direct the migration of NSCs toward the ischemic core and penumbra (36) . Vasculature, in particular endothelial cells, contributes to SDF production (37) . It has been suggested that the SDF-1 endothelial expression acts as a signal indicating the presence of tissue ischemia and that its expression is directly regulated by hypoxia-inducible factor-1 (35) .
In our experiments, we used the intrabrain injection of SDF-1 to promote the homing of NSC from circulation; however, in the presence of CNS diseases such as inflammatory or ischemic disorders the already present expression of SDF and other factors could provide a sufficient chemotactic signal to allow recruitment of NSC transplanted intravenously in the absence of an exogenous injection of SDF.
SDF-1 and CXCR4 are expressed in complementary patterns during embryonic organogenesis and guide primordial stem cells to sites of rapid vasculogenesis. The SDF-1-CXCR4 interaction during injury likely recapitulates a developmental role in mammalian cerebrogenesis, as suggested by the CXCR4 expression of both nestin and RC2 positive cells within the germinal zone.
The intravenous administration of the SDF could be a possible strategy to enhance NSC homing. However, SDF normally acts as signpost for mobilizing and directing stem cells in the site where SDF is produced. marrow is the attraction of CXCR4-expressing HSCs to marrow stromal cell-produced SDF-1. Specific antagonism of SDF-1/CXCL12 binding to CXCR4 could be used clinically for mobilization of HSCs (38) . On the other hand, it has been described that forced intravenous expression of SDF leads to hematopoietic stem cell mobilization as well as migration of endothelial progenitors (39) ; thus, intravenous administration of SDF may induce systemic effects.
Current efforts are primarily focused on making gene therapy and stem cell mediated repairs efficient enough for clinical therapy. The CNS homing tendency of Le + CX + and their ability, particularly when stimulated in vitro using appropriate signals, to differentiate into diverse mature neuronal phenotypes and form appropriate long-distance connections, suggest that isolation of specific stem cell populations could offer major advantages for neuronal replacement and brain repair. 
